AGC Pharma Chemicals Expands its HPAPI Capabilities in Barcelona
This strategic expansion in Barcelona addresses the growing demand for HPAPI driven by advances in oncology and targeted therapies, where highly potent compounds are essential for developing more precise and effective treatments.
Active Pharmaceutical Ingredients | 06/02/2025 | By Aishwarya
Zydus Takeda Healthcare Celebrates 25 Years of Manufacturing Operations in India
Over the past 25 years, the manufacturing site at Vashi has emerged as a supplier of APIs and intermediates for Takeda’s markets in Europe, Japan, Brazil, and Korea.
Active Pharmaceutical Ingredients | 31/01/2025 | By Aishwarya
Pharma Industry's Wishlist for Budget 2025: Key Expectations
The forthcoming Union Budget 2025 presents a pivotal opportunity for the Indian pharmaceutical sector to address existing challenges and pave the way for sustainable growth.
Active Pharmaceutical Ingredients | 22/01/2025 | By Aishwarya | 318
Glenmark Life Sciences Rebrands its Identity as Alivus Life Sciences
The new identity, Alivus Life Sciences, represents vitality and growth with a renewed focus.
Active Pharmaceutical Ingredients | 20/01/2025 | By Aishwarya | 451
Agilent Announces Acquisition of BIOVECTRA
With the addition of BIOVECTRA, Agilent will expand its portfolio of CDMO services, add rapidly growing modalities, and bring world-class capabilities to support gene editing.
Active Pharmaceutical Ingredients | 24/09/2024 | By Aishwarya | 245
Lonza Inaugurates Innovaform Accelerator CoE in France
The new Innovaform Accelerator will serve as a Center of Excellence (CoE) for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.
Active Pharmaceutical Ingredients | 20/09/2024 | By Aishwarya | 125
Nusano and PharmaLogic to Offer Current and Emerging Radiopharmaceuticals
Nusano Inc. has inked a supply agreement with PharmaLogic to provide a more efficient and reliable supply of critical radioisotopes.
Active Pharmaceutical Ingredients | 11/07/2024 | By Aishwarya
Lupin Names Abdelaziz Toumi as CEO of its Subsidiary
Lupin has appointed Abdelaziz Toumi (Abdel) as the Chief Executive Officer of its newly formed subsidiary, Lupin Manufacturing Solutions (LMS).
Active Pharmaceutical Ingredients | 18/06/2024 | By Aishwarya | 242
Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility
The Dahej facility was placed under OAI by the USFDA based on the March 2019 Inspection outcome.
Active Pharmaceutical Ingredients | 25/08/2023 | By Manvi | 774
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy